Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nordic 7.6: Alternating chemotherapy plus cetuximab in potentially resectable metastatic colorectal cancer (KRAS/BRAF wild-type)
2011-004188-65Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Dec 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cetuximab in colorectal cancer (CRC) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Response rate. Started Dec 2011; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2011-004188-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004188-65.